Cite

    Fu, W., Liu, Y., Xia, L., Li, M., Song, Z., Hu, H., Yang, Z., Wang, L., Cheng, X., Wang, M., Jiang, R., Liu, L., Mao, X., Chen, J., Ling, Y., Zhang, L., Yan, J., Shan, F., Steinhart, C., Zhang, X., Zhu, T., Xu, J., & Lu, H. (2020). a clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19. EClinicalMedicine, 25, . http://access.bl.uk/ark:/81055/vdc_100107602843.0x000001